Vincent Launay‐Vacher

22.4k total citations · 1 hit paper
158 papers, 16.3k citations indexed

About

Vincent Launay‐Vacher is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Vincent Launay‐Vacher has authored 158 papers receiving a total of 16.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pediatrics, Perinatology and Child Health, 47 papers in Pulmonary and Respiratory Medicine and 31 papers in Oncology. Recurrent topics in Vincent Launay‐Vacher's work include Pharmacological Effects and Toxicity Studies (46 papers), Chemotherapy-induced organ toxicity mitigation (23 papers) and Renal cell carcinoma treatment (22 papers). Vincent Launay‐Vacher is often cited by papers focused on Pharmacological Effects and Toxicity Studies (46 papers), Chemotherapy-induced organ toxicity mitigation (23 papers) and Renal cell carcinoma treatment (22 papers). Vincent Launay‐Vacher collaborates with scholars based in France, United States and Switzerland. Vincent Launay‐Vacher's co-authors include Gilbert Deray, Kenar D. Jhaveri, Rimda Wanchoo, Craig Devoe, Nupur N. Uppal, Valerie S. Barta, Gilbert Deray, Hassane Izzedine, Nicolas Janus and Corinne Isnard Bagnis and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Vincent Launay‐Vacher

150 papers receiving 16.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review

2017 11.6k citations Rimda Wanchoo, Nupur N. Uppal et al. American Journal of Nephrology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vincent Launay‐Vacher France	40	10.6k	4.8k	4.4k	2.5k	1.3k	158	16.3k
Gilbert Deray France	24	9.8k 0.9×	4.0k 0.8×	4.3k 1.0×	2.2k 0.9×	701 0.5×	115	13.3k
Piotr Rutkowski Poland	65	8.8k 0.8×	7.9k 1.6×	2.5k 0.6×	4.9k 2.0×	1.3k 1.0×	912	20.3k
John A. Glaspy United States	75	10.9k 1.0×	2.3k 0.5×	5.3k 1.2×	5.1k 2.0×	1.0k 0.8×	338	21.4k
Eitan Amir Canada	57	8.8k 0.8×	3.9k 0.8×	1.4k 0.3×	2.6k 1.0×	1.1k 0.8×	416	15.4k
Isabelle Ray‐Coquard France	64	7.0k 0.7×	5.5k 1.1×	1.8k 0.4×	2.8k 1.1×	1.9k 1.5×	418	16.7k
Evangelos Terpos Greece	77	11.7k 1.1×	1.4k 0.3×	1.7k 0.4×	8.6k 3.4×	1.3k 1.0×	869	23.7k
Bella Kaufman Israel	54	8.1k 0.8×	3.7k 0.8×	624 0.1×	4.4k 1.7×	1.0k 0.8×	250	15.2k
Emilio Bajetta Italy	55	10.4k 1.0×	5.8k 1.2×	1.2k 0.3×	3.9k 1.6×	1.3k 1.0×	325	16.6k
Michele Baccarani Italy	80	5.9k 0.6×	1.4k 0.3×	3.1k 0.7×	4.9k 2.0×	4.5k 3.4×	711	29.1k
Richard Greil Austria	67	10.9k 1.0×	4.1k 0.9×	2.7k 0.6×	5.3k 2.1×	4.2k 3.2×	731	20.1k

Countries citing papers authored by Vincent Launay‐Vacher

Since Specialization

Citations

This map shows the geographic impact of Vincent Launay‐Vacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Launay‐Vacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Launay‐Vacher more than expected).

Fields of papers citing papers by Vincent Launay‐Vacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Launay‐Vacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Launay‐Vacher. The network helps show where Vincent Launay‐Vacher may publish in the future.

Co-authorship network of co-authors of Vincent Launay‐Vacher

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Launay‐Vacher. A scholar is included among the top collaborators of Vincent Launay‐Vacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Launay‐Vacher. Vincent Launay‐Vacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Launay‐Vacher, Vincent, Alexandre Bleibtreu, Perrine Bortolotti, et al.. (2019). Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice. Médecine et Maladies Infectieuses. 50(4). 323–331. 20 indexed citations

Wanchoo, Rimda, Nupur N. Uppal, Valerie S. Barta, et al.. (2017). Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review. American Journal of Nephrology. 45(2). 160–169. 11620 indexed citations breakdown →

Launay‐Vacher, Vincent, Nicolas Janus, & Gilbert Deray. (2016). Renal insufficiency and cancer treatments. ESMO Open. 1(4). e000091–e000091. 54 indexed citations

Janus, Nicolas, Jean-Pierre Laroche, Isabelle Mahé, & Vincent Launay‐Vacher. (2015). Maladie thromboembolique veineuse : faut-il encore évaluer la fonction rénale du patient avant un traitement anticoagulant ?. Journal de Pharmacie Clinique. 34(2). 57–65. 1 indexed citations

Launay‐Vacher, Vincent, Matti Aapro, Gilberto de Castro, et al.. (2015). Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN). Annals of Oncology. 26(8). 1677–1684. 55 indexed citations

Janus, Nicolas, Vincent Launay‐Vacher, Gilbert Deray, A. Thyss, & Juliette Thariat. (2012). Gestion des chimiothérapies chez les patients hémodialysés. Bulletin du Cancer. 99(3). 371–380. 7 indexed citations

Scotté, Florian, Jean‐Baptiste Rey, & Vincent Launay‐Vacher. (2012). Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroads. Supportive Care in Cancer. 20(12). 3033–3042. 27 indexed citations

Launay‐Vacher, Vincent, et al.. (2011). Adaptation posologique des médicaments chez le patient insuffisant rénal chronique. Journal de Pharmacie Clinique. 30(4). 223–228. 1 indexed citations

Janus, Nicolas & Vincent Launay‐Vacher. (2011). Complication de l’insuffisance rénale chronique : l’anémie et ses traitements. Journal de Pharmacie Clinique. 30(4). 229–234. 2 indexed citations

10.

Rey, Jean‐Baptiste & Vincent Launay‐Vacher. (2011). Utilisation des héparines de bas poids moléculaire (HBPM) chez le patient insuffisant rénal en milieu hospitalier. Journal de Pharmacie Clinique. 30(2). 61–74. 2 indexed citations

11.

Janus, Nicolas, et al.. (2010). Vaccination et insuffisance rénale chronique. Journal de Pharmacie Clinique. 29(3). 149–157.

12.

Janus, Nicolas, Vincent Launay‐Vacher, J-P. Machiels, et al.. (2010). Cancer and renal insufficiency results of the BIRMA study. British Journal of Cancer. 103(12). 1815–1821. 133 indexed citations

13.

Rey, Jean‐Baptiste, Joseph Gligorov, & Vincent Launay‐Vacher. (2006). Point sur la prise en charge des métastases osseuses avec les bisphosphonates IV en cancérologie. Journal de Pharmacie Clinique. 25(3). 129–137. 1 indexed citations

14.

Launay‐Vacher, Vincent, Hassane Izzedine, A Baumelou, & Gilbert Deray. (2005). F<sub>HD</sub>: An Index to Evaluate Drug Elimination by Hemodialysis. American Journal of Nephrology. 25(4). 342–351. 11 indexed citations

15.

Karie, Svetlana, Vincent Launay‐Vacher, Hassan Izzedine, & Gilbert Deray. (2005). Néphropathie induite par les produits de contraste iodés, l’épuration extrarénale est-elle efficace en prevention ?. La Presse Médicale. 34(11). 803–808. 1 indexed citations

16.

Izzedine, Hassane, Vincent Launay‐Vacher, Irina Buhăescu, et al.. (2005). PPAR-gamma-agonists' renal effects.. PubMed. 57(4). 247–60. 16 indexed citations

17.

Izzedine, Hassane, Vincent Launay‐Vacher, Corinne Isnard Bagnis, & Gilbert Deray. (2003). Drug-induced Fanconi's syndrome. American Journal of Kidney Diseases. 41(2). 292–309. 166 indexed citations

18.

Izzedine, Hassane, Bahram Bodaghi, Vincent Launay‐Vacher, & Gilbert Deray. (2003). Eye and Kidney. Journal of the American Society of Nephrology. 14(2). 516–529. 52 indexed citations

19.

Izzedine, Hassane, Vincent Launay‐Vacher, André Grimaldi, & Gilbert Deray. (2002). [How and when to search for a renal artery atheromatous stenosis in diabetic patients?].. PubMed. 28(3). 244–9. 2 indexed citations

20.

Izzedine, Hassane, Vincent Launay‐Vacher, Magali Ciroldi, L. Fardet, & Gilbert Deray. (2002). Fanconi and Inappropriate Secretion of Antidiuretic Hormone Syndromes Secondary to Venlafaxine Therapy. The Nephron journals/Nephron journals. 92(4). 944–946. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact